Waari Gabriel, Mutai Joseph, Gikunju Joseph
School of Public Health, Institute of Tropical Medicine and Infectious Diseases, Jomo Kenyatta University of Agriculture and Technology, Kenya.
Centre for Public Health Research, Kenya Medical Research Institute.
Pan Afr Med J. 2018 Jan 29;29:82. doi: 10.11604/pamj.2018.29.82.12639. eCollection 2018.
Medication non-adherence is a common problem facing health care providers treating adult type 2 diabetes mellitus patients. Poor glycaemic control associated with increased morbidity and mortality are resulting consequences. The objective of this study was to assess medication adherence among Type 2 diabetes mellitus patients.
This is a cross-sectional study conducted at Kenyatta National Hospital from November 2015 to January 2016. 290 Type 2 diabetic patients were enrolled. A questionnaire was used for data collection. Adherence levels were determined by patient scores on Morisky Medication Adherence Scale-8 and glycaemic control by blood assay for glycosylated haemoglobin. Ordinal logistic regression modelling was done using STATA software to determine factors associated with poor medication adherence.
The prevalence of medication adherence low for 28.3 % [95% CI: 23.1, 33.5], medium for 26.2% (95% CI: 21.1, 31.3) and high for 45.5% (95% CI: 39.6, 51.3) of study participants. Glycaemic control was good (HbA1c < 7%) for 107 (36.9 %) of study participants. Dissatisfaction with family members support (OR = 2.99, CI = 1.12-7.98), patients with 2-10 years duration of disease (OR = 2.07, CI = 1.01-4.22), ever being admitted for diabetes mellitus (OR = 2.94, CI = 1.60-5.41), challenge in drug access (OR = 1.76, CI = 1.01-3.05) and dissatisfaction with attending clinicians (OR = 3.58, CI= 1.36 - 9.43) were factors found associated with poor medication adherence.
A majority of type 2 diabetes mellitus patients have suboptimal medication adherence. Family support, affordability of medications and good healthcare provider-patient communication are important in ensuring medication adherence.
药物治疗依从性不佳是治疗成年2型糖尿病患者的医护人员面临的常见问题。与之相关的血糖控制不佳会导致发病率和死亡率上升。本研究的目的是评估2型糖尿病患者的药物治疗依从性。
这是一项于2015年11月至2016年1月在肯雅塔国家医院开展的横断面研究。纳入了290名2型糖尿病患者。使用问卷进行数据收集。依从性水平通过患者在莫里斯基药物治疗依从性量表-8上的得分来确定,血糖控制情况则通过糖化血红蛋白血液检测来评估。使用STATA软件进行有序逻辑回归建模,以确定与药物治疗依从性差相关的因素。
研究参与者中,药物治疗依从性低的患病率为28.3%[95%置信区间:23.1,33.5],中等的为26.2%(95%置信区间:21.1,31.3),高的为45.5%(95%置信区间:39.6,51.3)。107名(36.9%)研究参与者的血糖控制良好(糖化血红蛋白<7%)。对家庭成员支持不满意(比值比=2.99,置信区间=1.12 - 7.98)、病程为2至10年的患者(比值比=2.07,置信区间=1.01 - 4.22)、曾因糖尿病住院(比值比=2.94,置信区间=1.60 - 5.41)、获取药物困难(比值比=1.76,置信区间=1.01 - 3.05)以及对主治医生不满意(比值比=3.58,置信区间=1.36 - 9.43)是与药物治疗依从性差相关的因素。
大多数2型糖尿病患者的药物治疗依从性欠佳。家庭支持、药物可负担性以及良好的医护人员与患者沟通对于确保药物治疗依从性很重要。